2012
DOI: 10.1038/leu.2012.35
|View full text |Cite
|
Sign up to set email alerts
|

Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia

Abstract: Childhood myelodysplastic syndromes (MDS) are a heterogeneous group of stem cell disorders characterized by peripheral blood cytopenia, ineffective hematopoiesis, hyper- or hypocellular bone marrow (BM) and propensity to evolve into acute myeloid leukemia (AML) in approximately 30–40% of cases.1, 2, 3\ud \ud Childhood MDS are rare diseases and several differences between adult and pediatric MDS have been recognized.1 MDS in pediatric patients is classified, using morphological criteria, into refractory cytopen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 15 publications
0
6
0
Order By: Relevance
“…This analysis showed that two distinct groups of MDS patients were generated although the mean age between the two groups was not statistically significantly different. One included four high-risk MDS patients (whose disease evolved into AML in a median interval between diagnosis and evolution of 225 days, range 59-714 days) and the other included low-risk MDS patients (whose disease had not evolved at the time of the study from 3-10 years after diagnosis) 26 ( Figure 2D). Therefore, differential expression of CREB target genes marks MDS, high-risk MDS (MDS that evolved) and AML, supporting the role of miR-34b and CREB in the process of myeloid transformation.…”
Section: Mir-34b Promoter Hypermethylation Occurs During Transformatimentioning
confidence: 99%
See 1 more Smart Citation
“…This analysis showed that two distinct groups of MDS patients were generated although the mean age between the two groups was not statistically significantly different. One included four high-risk MDS patients (whose disease evolved into AML in a median interval between diagnosis and evolution of 225 days, range 59-714 days) and the other included low-risk MDS patients (whose disease had not evolved at the time of the study from 3-10 years after diagnosis) 26 ( Figure 2D). Therefore, differential expression of CREB target genes marks MDS, high-risk MDS (MDS that evolved) and AML, supporting the role of miR-34b and CREB in the process of myeloid transformation.…”
Section: Mir-34b Promoter Hypermethylation Occurs During Transformatimentioning
confidence: 99%
“…RNA quality was assessed on an Agilent2100 Bioanalyzer (Agilent Technologies). The GeneChip Human Genome U133 Plus 2.0 was used for the microarray experiments, as previously described [23][24][25][26] (Online Supplementary Design and Methods). …”
Section: Gene Expression Analysismentioning
confidence: 99%
“…Over the past 20 years, the protein complexes of S100A8 and S100A9 have emerged as very potent biomarkers of a wide range of inflammatory processes (Healy et al, 2006;Bresolin et al, 2012). Therefore, we speculate that S100A8 and S100A9 and the proteins with which they interact not only serve as useful markers of inflammation, but also play critical roles in the pathogenesis of inflammatory disorders.…”
Section: Discussionmentioning
confidence: 99%
“…These transcription factors are known regulators of hematopoietic stem cell proliferation [35][36][37][38] and are normally expressed at high levels in hematopoietic stem cells relative to more differentiated myelomonocytic cells [39][40][41][42]. Moreover, their activity has been implicated in myeloid leukemia [43][44][45][46], and expression of Gata2 and Hoxa9 has been demonstrated to be elevated in patients with myelodysplastic syndrome (MDS) [47][48][49][50]. qPCR revealed large increases in the transcript levels (8-to >200-fold) of all three genes in Rcor1-deficient Mac1 1 Gr1 lo cells relative to controls (Fig.…”
Section: Transcription Factors That Regulate Stem/progenitor Cell Promentioning
confidence: 99%